AGC Introduces New Surfactant- and Fluorinated Solvent-Free Grades in AFLAS™ FFKM Series

AGC (AGC Inc., Headquarters: Tokyo; President: Yoshinori Hirai)(TOKYO:5201), a world-leading manufacturer of glass, chemicals and other high-tech materia...

July 18, 2025 | Friday | News
10x Genomics and A*STAR GIS Launch Landmark Spatial Biology Study in Asia to Drive Cancer and Inflammation Breakthroughs

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases 10x Gen...

July 18, 2025 | Friday | News
Qualigen Secures Broad Patent Coverage for QN-302 Across Over 20 European Nations, India, China, and Russia

Qualigen Therapeutics, Inc. is announcing an update on patents granted in the first six months of 2025. The patent is Titled “Substitued Naphthalen...

July 17, 2025 | Thursday | News
Biocon Biologics Secures FDA Approval for Kirsty™, the First Interchangeable Biosimilar to NovoLog® in the U.S.

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. announced that the U.S. Food and Drug Administrat...

July 16, 2025 | Wednesday | News
Waters and BD Strike $17.5B Strategic Combination

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution...

July 15, 2025 | Tuesday | News
iFIT and Samsung Health Partner to Redefine Connected Fitness and Personalised Healthcare Globally

iFIT, a global leader in connected fitness and interactive content,  announced a groundbreaking partnership with Samsung Health, one of the world&rs...

July 14, 2025 | Monday | News
Golden Age Health and Innostellar Sign Exclusive 10-Year Deal to Deliver Sight-Saving Gene Therapy LX-101 Across China

Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”)  announced an exclusive ten-ye...

July 14, 2025 | Monday | News
Ascentage Pharma Secures China’s First Approval for Bcl-2 Inhibitor in CLL/SLL with Lisaftoclax

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it...

July 11, 2025 | Friday | News
Hongene Biotech Powers IND-Cleared siRNA Therapy DNV001 with End-to-End CDMO Capabilities

Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) specializing in nucleic acid therapeutics,  announced its ...

July 11, 2025 | Friday | News
Zhimeng Biopharma Receives CDE Approval to Advance CB03-154 into Phase 2/3 Trials for ALS in China

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and...

July 10, 2025 | Thursday | News
Japan’s Chugai and Singapore’s Gero Join Forces to Advance Antibody Therapies Targeting Aging via AI and Human Data

Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through...

July 08, 2025 | Tuesday | News
Nxera Pharma to Receive US$4.8 Million in Milestone Payments as Centessa Advances Orexin Agonist into Clinical Development

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone paym...

July 07, 2025 | Monday | News
Abinopharm Reports Positive Clinical Trial Outcomes for Oral Dr.Ergo® L-Ergothioneine in Enhancing Skin Health

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EG...

July 07, 2025 | Monday | News
Asahi Kasei Pharma Begins Phase III Trial in Japan of ART-123 for Preventing Chemotherapy-Induced Peripheral Neuropathy

Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: thrombomodulin alfa; marketed as Recomod...

July 03, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close